Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adverse Effect of Other Antipsychotics and Neuroleptics”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Post-approval studies (Phase 4)Study completedNCT00245206
What this trial is testing

Side Effects of Newer Antipsychotics in Older Adults

Who this might be right for
SchizophreniaAlzheimer's DiseaseDementia
Veterans Medical Research Foundation 406
Not applicableStudy completedNCT00677898
What this trial is testing

A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)

Who this might be right for
SchizophreniaPsychotic Disorders
US Department of Veterans Affairs 239
Post-approval studies (Phase 4)Study completedNCT00682448
What this trial is testing

Metformin for the Prevention of the Metabolic Side-effects of Zyprexa

Who this might be right for
Metabolic Complications
Rush University Medical Center 25
Not applicableUnknownNCT01966588
What this trial is testing

Adverse Events and Genomics in Schizophrenia

Who this might be right for
Adverse Effect of Other Antipsychotics and Neuroleptics
University of British Columbia 100
Post-approval studies (Phase 4)Study completedNCT00932529
What this trial is testing

Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting

Who this might be right for
Psychotic Disorders
University of Bergen 226
Not applicableLooking for participantsNCT06624462
What this trial is testing

Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

Who this might be right for
Severe Mental DisorderMetabolic ComplicationSide-Effect;Medication+2 more
Bjorn H. Ebdrup 84
Not applicableStudy completedNCT00363181
What this trial is testing

Side Effects of Antipsychotic Medications

Who this might be right for
Insulin ResistanceMetabolic Syndrome XSchizophrenia and Disorders With Psychotic Features+2 more
Stanford University 76
Not applicableStudy completedNCT00815854
What this trial is testing

Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects

Who this might be right for
Schizophrenia
University of Michigan 88
Not applicableStudy completedNCT01875861
What this trial is testing

Monitoring and Management for Metabolic Side Effects of Antipsychotics

Who this might be right for
Mental HealthPsychotic Disorders
VA Office of Research and Development 12
Large-scale testing (Phase 3)Study completedNCT00419146
What this trial is testing

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder+1 more
University Hospital, Aker 99
Not applicableStudy completedNCT01739127
What this trial is testing

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

Who this might be right for
Psychotic DisordersBipolar DisorderMetabolic Syndrome X
University of British Columbia 83
Very early researchStudy completedNCT02708394
What this trial is testing

Molecular Mechanisms of Antipsychotic-induced Insulin Resistance

Who this might be right for
Adverse Effect of Other Antipsychotics and NeurolepticsInsulin Resistance
Wayne State University 31
Not applicableStudy completedNCT06326840
What this trial is testing

Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment

Who this might be right for
Metabolic DisturbanceHyperprolactinemiaSchizophrenia
Taipei Medical University Hospital 42
Post-approval studies (Phase 4)WithdrawnNCT02286206
What this trial is testing

Study of the Effect of Dosing on Clozapine Levels

Who this might be right for
Psychotic DisordersSchizophrenia
University of British Columbia
Not applicableStudy completedNCT03451734
What this trial is testing

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Who this might be right for
SchizophreniaMetabolic Syndrome
Central South University 2,000
Post-approval studies (Phase 4)WithdrawnNCT01567124
What this trial is testing

Alleviating the Metabolic Side Effects of Antipsychotic Medications

Who this might be right for
Schizophrenia
Baker Heart and Diabetes Institute
Not applicableStudy completedNCT00206960
What this trial is testing

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 56
Not applicableStudy completedNCT02582736
What this trial is testing

Antipsychotics and Risk of Hyperglycemic Emergencies

Who this might be right for
Psychotic DisordersSchizophreniaSchizoaffective Disorder+2 more
Canadian Network for Observational Drug Effect Studies, CNODES 725,489
Not applicableUnknownNCT02964923
What this trial is testing

Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Xijing Hospital 300
Post-approval studies (Phase 4)Study completedNCT01050582
What this trial is testing

Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Who this might be right for
SchizophreniaBipolar DisorderAutistic Disorder+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244
Load More Results